[Therapy of circulatory disorders of the brain and spinal cord].
D000367:Age Factors; D000925:Anticoagulants / Q000627:therapeutic use; D001929:Brain Edema / Q000188:drug therapy; D002543:Cerebral Hemorrhage / Q000628:therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D003327:Coronary Disease / Q000150:complications; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004691:Endarterectomy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006982:Hypertonic Solutions / Q000627:therapeutic use; D007022:Hypotension / Q000150:complications; D007238:Infarction; D002542:Intracranial Embolism and Thrombosis / Q000628:therapy; D002546:Ischemic Attack, Transient / Q000628:therapy; D008750:Methyldopa / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D010952:Plasma Substitutes / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000150:complications; D013116:Spinal Cord; D013233:Stellate Ganglion / Q000601:surgery; D013349:Subclavian Steal Syndrome / Q000601:surgery; D013565:Sympatholytics / Q000627:therapeutic use; D014652:Vascular Diseases / Q000628:therapy*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000925:Anticoagulants; D004071:Digitalis Glycosides; D006982:Hypertonic Solutions; D010952:Plasma Substitutes; D013565:Sympatholytics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D008750:Methyldopa; D012110:Reserpine
Therapie der Zirkulationsstörungengen des Gehirns und des Rückenmarks.